
### [MONDO:0005794](http://purl.obolibrary.org/obo/MONDO_0005794)
**Label:** Herpesviridae infectious disease

**Subclasses:** [MONDO:0018108](http://purl.obolibrary.org/obo/MONDO_0018108) (idiopathic disseminated cytomegalovirus infection), [MONDO:0014680](http://purl.obolibrary.org/obo/MONDO_0014680) (herpes simplex encephalitis, susceptibility to, 7), [MONDO:0013075](http://purl.obolibrary.org/obo/MONDO_0013075) (herpes simplex encephalitis, susceptibility to, 2), [MONDO:0000337](http://purl.obolibrary.org/obo/MONDO_0000337) (exanthema subitum), [MONDO:0005608](http://purl.obolibrary.org/obo/MONDO_0005608) (varicella zoster infection), [MONDO:0005609](http://purl.obolibrary.org/obo/MONDO_0005609) (herpes zoster), [MONDO:0015292](http://purl.obolibrary.org/obo/MONDO_0015292) (endotheliitis), [MONDO:0004616](http://purl.obolibrary.org/obo/MONDO_0004616) (herpetic whitlow), [MONDO:0005769](http://purl.obolibrary.org/obo/MONDO_0005769) (geniculate herpes zoster), [MONDO:0015291](http://purl.obolibrary.org/obo/MONDO_0015291) (stromal keratitis), [MONDO:0004712](http://purl.obolibrary.org/obo/MONDO_0004712) (herpes simplex dermatitis), [MONDO:0005700](http://purl.obolibrary.org/obo/MONDO_0005700) (chickenpox), [MONDO:0005883](http://purl.obolibrary.org/obo/MONDO_0005883) (ophthalmic herpes zoster), [MONDO:0005187](http://purl.obolibrary.org/obo/MONDO_0005187) (human herpesvirus 8 infection), [MONDO:0012521](http://purl.obolibrary.org/obo/MONDO_0012521) (herpes simplex encephalitis), [MONDO:0015289](http://purl.obolibrary.org/obo/MONDO_0015289) (infectious epithelial keratitis), [MONDO:0015288](http://purl.obolibrary.org/obo/MONDO_0015288) (herpes simplex virus keratitis), [MONDO:0004609](http://purl.obolibrary.org/obo/MONDO_0004609) (herpes simplex), [MONDO:0017381](http://purl.obolibrary.org/obo/MONDO_0017381) (congenital herpes simplex virus infection), [MONDO:0005810](http://purl.obolibrary.org/obo/MONDO_0005810) (infectious mononucleosis), [MONDO:0000286](http://purl.obolibrary.org/obo/MONDO_0000286) (Epstein-Barr virus hepatitis), [MONDO:0005132](http://purl.obolibrary.org/obo/MONDO_0005132) (cytomegalovirus infection), [MONDO:0005770](http://purl.obolibrary.org/obo/MONDO_0005770) (genital herpes), [MONDO:0005792](http://purl.obolibrary.org/obo/MONDO_0005792) (herpes simplex virus gingivostomatitis), [MONDO:0017409](http://purl.obolibrary.org/obo/MONDO_0017409) (fetal cytomegalovirus syndrome), [MONDO:0013920](http://purl.obolibrary.org/obo/MONDO_0013920) (herpes simplex encephalitis, susceptibility to, 3), [MONDO:0013921](http://purl.obolibrary.org/obo/MONDO_0013921) (herpes simplex encephalitis, susceptibility to, 4), 

**Mapped go classes:** [GO:0008063](http://purl.obolibrary.org/obo/GO_0008063) (Toll signaling pathway), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:1900017](http://purl.obolibrary.org/obo/GO_1900017) (positive regulation of cytokine production involved in inflammatory response), [GO:0032727](http://purl.obolibrary.org/obo/GO_0032727) (positive regulation of interferon-alpha production), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0002756](http://purl.obolibrary.org/obo/GO_0002756) (MyD88-independent toll-like receptor signaling pathway), [GO:0032728](http://purl.obolibrary.org/obo/GO_0032728) (positive regulation of interferon-beta production), [GO:0050715](http://purl.obolibrary.org/obo/GO_0050715) (positive regulation of cytokine secretion), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0031996](http://purl.obolibrary.org/obo/GO_0031996) (thioesterase binding), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:2001184](http://purl.obolibrary.org/obo/GO_2001184) (positive regulation of interleukin-12 secretion), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0019903](http://purl.obolibrary.org/obo/GO_0019903) (protein phosphatase binding), [GO:0000902](http://purl.obolibrary.org/obo/GO_0000902) (cell morphogenesis), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0030890](http://purl.obolibrary.org/obo/GO_0030890) (positive regulation of B cell proliferation), [GO:0050689](http://purl.obolibrary.org/obo/GO_0050689) (negative regulation of defense response to virus by host), [GO:0035666](http://purl.obolibrary.org/obo/GO_0035666) (TRIF-dependent toll-like receptor signaling pathway), [GO:0050688](http://purl.obolibrary.org/obo/GO_0050688) (regulation of defense response to virus), [GO:0045429](http://purl.obolibrary.org/obo/GO_0045429) (positive regulation of nitric oxide biosynthetic process), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0008565](http://purl.obolibrary.org/obo/GO_0008565) (protein transporter activity), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0097342](http://purl.obolibrary.org/obo/GO_0097342) (ripoptosome), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:2000778](http://purl.obolibrary.org/obo/GO_2000778) (positive regulation of interleukin-6 secretion), [GO:0034162](http://purl.obolibrary.org/obo/GO_0034162) (toll-like receptor 9 signaling pathway), [GO:0043496](http://purl.obolibrary.org/obo/GO_0043496) (regulation of protein homodimerization activity), [GO:0002224](http://purl.obolibrary.org/obo/GO_0002224) (toll-like receptor signaling pathway), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0032816](http://purl.obolibrary.org/obo/GO_0032816) (positive regulation of natural killer cell activation), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0001817](http://purl.obolibrary.org/obo/GO_0001817) (regulation of cytokine production), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0034154](http://purl.obolibrary.org/obo/GO_0034154) (toll-like receptor 7 signaling pathway), [GO:0002281](http://purl.obolibrary.org/obo/GO_0002281) (macrophage activation involved in immune response), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0032009](http://purl.obolibrary.org/obo/GO_0032009) (early phagosome), [GO:0032648](http://purl.obolibrary.org/obo/GO_0032648) (regulation of interferon-beta production), [GO:0050871](http://purl.obolibrary.org/obo/GO_0050871) (positive regulation of B cell activation), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0031398](http://purl.obolibrary.org/obo/GO_0031398) (positive regulation of protein ubiquitination), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0035631](http://purl.obolibrary.org/obo/GO_0035631) (CD40 receptor complex), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0005164](http://purl.obolibrary.org/obo/GO_0005164) (tumor necrosis factor receptor binding), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0010508](http://purl.obolibrary.org/obo/GO_0010508) (positive regulation of autophagy), [GO:0033209](http://purl.obolibrary.org/obo/GO_0033209) (tumor necrosis factor-mediated signaling pathway), [GO:0001878](http://purl.obolibrary.org/obo/GO_0001878) (response to yeast), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0034138](http://purl.obolibrary.org/obo/GO_0034138) (toll-like receptor 3 signaling pathway), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:0032755](http://purl.obolibrary.org/obo/GO_0032755) (positive regulation of interleukin-6 production), [GO:0060340](http://purl.obolibrary.org/obo/GO_0060340) (positive regulation of type I interferon-mediated signaling pathway), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0097300](http://purl.obolibrary.org/obo/GO_0097300) (programmed necrotic cell death), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0045351](http://purl.obolibrary.org/obo/GO_0045351) (type I interferon biosynthetic process), [GO:0043330](http://purl.obolibrary.org/obo/GO_0043330) (response to exogenous dsRNA), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0140052](http://purl.obolibrary.org/obo/GO_0140052) (cellular response to oxidised low-density lipoprotein particle stimulus), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0034121](http://purl.obolibrary.org/obo/GO_0034121) (regulation of toll-like receptor signaling pathway), [GO:0030162](http://purl.obolibrary.org/obo/GO_0030162) (regulation of proteolysis), [GO:0045358](http://purl.obolibrary.org/obo/GO_0045358) (negative regulation of interferon-beta biosynthetic process), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0045359](http://purl.obolibrary.org/obo/GO_0045359) (positive regulation of interferon-beta biosynthetic process), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0035325](http://purl.obolibrary.org/obo/GO_0035325) (Toll-like receptor binding), [GO:0045080](http://purl.obolibrary.org/obo/GO_0045080) (positive regulation of chemokine biosynthetic process), 

**Class expressions from DL-Learner:**

- Thing 53.50%
- [GO:0034162](http://purl.obolibrary.org/obo/GO_0034162) (toll-like receptor 9 signaling pathway) 51.67%
- [GO:0034154](http://purl.obolibrary.org/obo/GO_0034154) (toll-like receptor 7 signaling pathway) 51.67%
- [GO:0034138](http://purl.obolibrary.org/obo/GO_0034138) (toll-like receptor 3 signaling pathway) 51.67%
- [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II) 51.67%
- [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II) 51.67%
- [GO:0002495](http://purl.obolibrary.org/obo/GO_0002495) (antigen processing and presentation of peptide antigen via MHC class II) 51.67%
- [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II) and [GO:0048002](http://purl.obolibrary.org/obo/GO_0048002) (antigen processing and presentation of peptide antigen) 51.67%
- [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II) and [GO:0019884](http://purl.obolibrary.org/obo/GO_0019884) (antigen processing and presentation of exogenous antigen) 51.67%
- [GO:0002495](http://purl.obolibrary.org/obo/GO_0002495) (antigen processing and presentation of peptide antigen via MHC class II) and [GO:0019884](http://purl.obolibrary.org/obo/GO_0019884) (antigen processing and presentation of exogenous antigen) 51.67%
- [GO:0002478](http://purl.obolibrary.org/obo/GO_0002478) (antigen processing and presentation of exogenous peptide antigen) and [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II) 51.67%
- [GO:0002478](http://purl.obolibrary.org/obo/GO_0002478) (antigen processing and presentation of exogenous peptide antigen) and [GO:0002495](http://purl.obolibrary.org/obo/GO_0002495) (antigen processing and presentation of peptide antigen via MHC class II) 51.67%
- [GO:0002224](http://purl.obolibrary.org/obo/GO_0002224) (toll-like receptor signaling pathway) 40.36%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 38.74%
- [GO:0048002](http://purl.obolibrary.org/obo/GO_0048002) (antigen processing and presentation of peptide antigen) 37.02%


